Iron deficiency
anemia is the most common form of anemia throughout the world. It is estimated
that two billion people suffer from iron deficiency anemia worldwide. To
address iron deficiency, iron therapy is important being the critical factor in
the production of red blood cells. Around 4.5 million Americans are diagnosed
and suffering from iron deficiency anemia (IDA).
Request a sample
of this report @ http://www.orbisresearch.com/contacts/request-sample/13497
Generally,
daily oral iron is the first line therapy for most IDA patient but for many
patients oral iron therapy fails as a consequence of compliance, efficacy and
side effects like constipation and gastro intestinal disorders. When oral
supplements fail to meet the requirement, intravenous (I.V.) iron therapy is
used, in which iron is directly injected with a needle into a vein. Iron given
intravenously allows larger amounts of iron to be provided to patients while
avoiding many of the side effects and treatment compliance issues associated
with oral iron, and can result in faster rises in hemoglobin levels. In the US,
a small fraction of non-dialysis CKD patients who are diagnosed with IDA are
currently being treated with I.V. iron, and thus a significant opportunity is
there for the market.
The key factors
driving growth of the global I.V. iron industry include iron deficiency in
hemodialysis patient cases, growing number of ERSD patients, prevalence of iron
deficiency in women, increasing global healthcare expenditure, increasing
global ageing population and large potential in new therapeutic areas. Some of
the noteworthy trends and developments of this industry are penetration of I.V.
iron in obstetrics and gynecology area, new product development and increase in
awareness of disease. However, the growth of this sector is hindered by
potential risks of using I.V. iron, emerging anemia management therapies and
strict regulatory structures.
The report
provides a comprehensive study of iron product market and I.V. iron market
globally. It also provides detailed information for key regional markets of I.V
iron industry. The competition in the global I.V. iron market is stiff among
large players like Galenica Group, AMAG Pharmaceuticals Inc. and Actavis Plc.
All these companies have been profiled in the present report highlighting their
key financials and business strategies for growth.
By combining SPSS
Inc.’s data integration and analysis capabilities with our relevant findings,
we have predicted the future growth of the industry. We employed various
significant variables that have an impact on this industry and created
regression models with SPSS Base to determine the future direction of the
industry. Before deploying the regression model, the relationship between
several independent or predictor variables and the dependent variable was
analyzed using standard SPSS output, including charts, tables and tests.
Purchase a copy of Intravenous
(I.V.) Iron Drugs Market visit @ http://www.orbisresearch.com/reports/index/-global-intravenous-iv-iron-drugs-market-report-2015-edition
Table Of
Content:
1.
Overview
1.1 I.V. Iron Application Areas
1.1.1 I.V. Iron Application in Nephrology
1.2 Iron Deficiency - Anemia
1.2.2 Iron Deficiency Metrics
1.3 I.V. Iron Therapies for Anemia Treatment
1.1 I.V. Iron Application Areas
1.1.1 I.V. Iron Application in Nephrology
1.2 Iron Deficiency - Anemia
1.2.2 Iron Deficiency Metrics
1.3 I.V. Iron Therapies for Anemia Treatment
2. Market
Analysis
2.1 Global Iron Product Market
-Market Value
-Market Segments
2.2.1 Global I.V. Iron Drug Market
-Market Value
-Product Share
2.2 Regional Analysis
2.2.1 The US I.V. Iron Drug Market
-Market Value
-Product Share
-Non-Dialysis IV Iron Market
2.2.2 European I.V. Iron Drug Market
-Market Value
-Product Share
2.2.3 Australian I.V. iron Drug Market
-Market Value
-Product Share
2.1 Global Iron Product Market
-Market Value
-Market Segments
2.2.1 Global I.V. Iron Drug Market
-Market Value
-Product Share
2.2 Regional Analysis
2.2.1 The US I.V. Iron Drug Market
-Market Value
-Product Share
-Non-Dialysis IV Iron Market
2.2.2 European I.V. Iron Drug Market
-Market Value
-Product Share
2.2.3 Australian I.V. iron Drug Market
-Market Value
-Product Share
For any enquires
before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone
No.: +1 (214) 884-6817;
+912064101019
No comments:
Post a Comment